NDC 69278-101-02 - Dr Cellapy SR Premium
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 69278-101
- Requested NDC
- 69278-101-02
- Package NDCs from labels
- 69278-101-01, 69278-101-02
- Manufacturer
- GM Holdings Co., Ltd
- Effective date
- 2020-01-21
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Dr. Cellapy SR Premium Solution - GM Holdings Co., Ltd | GM Holdings Co., Ltd | 2020-01-21 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 69278-101-01 | Dr Cellapy SR Premium | 5 mL in 1 VIAL | LIQUID | 5 mL | 0.005 in 5mL | 6 |
| 69278-101-02 | Dr Cellapy SR Premium | 5 in 1 BOX | LIQUID | 0.005 in 5mL | 6 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Potassium Chloride for Oral Solution | POTASSIUM CHLORIDE | Granules Pharmaceuticals Inc. | 727be945-df2a-4fbf-ade4-f242e2647976 | 2026-10-08 | Warnings, Adverse reactions | 660YQ98I10 |
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | Granules Pharmaceuticals Inc. | 302b3fa7-ea87-4bf1-aae0-6a2d7459de86 | 2026-10-08 | Warnings, Adverse reactions | 660YQ98I10 |
| GoLYTELY | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | Braintree Laboratories, Inc. | 57d22b0b-1ae0-4203-babc-f3bac17bd1c9 | 2026-10-08 | Warnings, Adverse reactions | 660YQ98I10 |
| PEG-3350 and Electrolytes | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | Affordable Pharmaceuticals, LLC | 448db7a5-1fea-4bf3-b1f5-e9d027a36603 | 2026-10-08 | Warnings, Adverse reactions | 660YQ98I10 |
| PEG-3350, sodium chloride, sodium bicarbonate and potassium chloride | POLYETHYLENE GLYCOL 3350, SODIUM CHLORIDE, SODIUM BICARBONATE, POTASSIUM CHLORIDE | Affordable Pharmaceuticals, LLC | 89ca6d56-527a-4be2-baea-531156f0a7be | 2026-10-08 | Warnings, Adverse reactions | 660YQ98I10 |
| SUPREP Bowel Prep | SODIUM SULFATE, POTASSIUM SULFATE, MAGNESIUM SULFATE | Braintree Laboratories, Inc. | 2f5f06de-ee98-44c0-be7e-9a998d1e5c16 | 2026-10-08 | Warnings, Adverse reactions | DE08037SAB |
| SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE | SODIUM SULFATE, POTASSIUM SULFATE, MAGNESIUM SULFATE | Affordable Pharmaceuticals, LLC | f86bdcc8-e643-4160-89ae-01c89bee842d | 2026-10-08 | Warnings, Adverse reactions | DE08037SAB |
| SUTAB | SODIUM SULFATE, MAGNESIUM SULFATE, AND POTASSIUM CHLORIDE | Braintree Laboratories, Inc. | dddd2701-4d46-44de-a9f8-303d4dcceef7 | 2026-10-08 | Warnings, Adverse reactions | 660YQ98I10 |
| Epsom Salt | MAGNESIUM SULFATE | Family Dollar (FAMILY WELLNESS) | 7de802aa-6c31-451c-995c-8549b2545c69 | 2026-10-07 | Warnings | DE08037SAB |
| Potassium Chloride Extended-release | POTASSIUM CHLORIDE EXTENDED-RELEASE | Granules India Ltd | 60285a8d-bcb0-40ba-b359-df5c89480cd6 | 2026-10-07 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | Granules India Ltd | 113c031c-6de3-4497-a57d-9740b1ce08ac | 2026-10-07 | Warnings, Adverse reactions | 660YQ98I10 |
| Epsom Salt | EPSOM SALT | P & L Development, LLC | a343bb9f-0b63-4464-99a0-f7137cd2125a | 2026-10-07 | Warnings | DE08037SAB |
| Epsom Salt | MAGNESIUM SULFATE | Whole Foods Market | 709ad74e-d95d-409d-bd7a-185411fc4bac | 2026-10-06 | Warnings | DE08037SAB |
| QUIOFIC | FOLIC ACID | Solubiomix, LLC | b868b314-591d-458b-be82-2bcd0b73cce1 | 2026-10-05 | Warnings, Adverse reactions | 935E97BOY8 |
| Epsom Salt | MAGNESIUM SULFATE | Harris Teeter, LLC | f55da148-81a3-49cc-bbde-6aef920b8903 | 2026-10-05 | Warnings | DE08037SAB |
| FOLIC ACID | FOLIC ACID | Ayurax, LLC | 96618bf8-6c03-4df3-9896-b7ef27ca392a | 2026-10-05 | Warnings, Adverse reactions | 935E97BOY8 |
| Epsom Salt | EPSOM SALT | Strategic Sourcing Services LLC | cfe04d1a-2a7d-48bd-876f-93a7c6186ba3 | 2026-10-02 | Warnings | DE08037SAB |
| Epsom Salt | MAGNESIUM SULFATE | Safeway, Inc. | 947ae6fe-05d9-4bcf-be73-b3e1a2c60227 | 2026-10-02 | Warnings | DE08037SAB |
| Epsom Salt | MAGNESIUM SULFATE | TOP CARE (Topco Associates LLC) | b1222ba6-390d-478d-905b-994fff4d6d58 | 2026-10-02 | Warnings | DE08037SAB |
| Potassium Chloride | POTASSIUM CHLORIDE | IPG Pharmaceuticals, Inc. | 5dad0879-0f97-4c7d-98fa-baaed51cd2d8 | 2026-10-01 | Warnings, Adverse reactions | 660YQ98I10 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.